SNB-19 Cells

The SNB-19 cell line is a human glioblastoma multiforme (GBM) model derived from a high-grade glioma tumor. It is one of the widely studied glioma cell lines and is used for exploring the biology of aggressive brain tumors, especially glioblastoma. SNB-19 cells exhibit epithelial morphology and are adherent in culture. They have been extensively used in studies of tumor proliferation, invasion, and response to therapy, particularly for investigating glioblastoma’s resistance mechanisms to conventional treatments.

Genomic profiling of SNB-19 cells has revealed important genetic alterations commonly associated with GBM, including mutations in tumor suppressor genes and oncogenes such as TP53, EGFR, and PTEN. These cells also demonstrate chromosomal abnormalities, including amplification of oncogenic drivers and deletions in tumor suppressor loci. The genetic landscape of SNB-19 provides an important model for studying the molecular pathways driving GBM pathogenesis and for identifying potential targets for therapy.

SNB-19 has been used extensively to evaluate the efficacy of novel chemotherapeutics and targeted agents. The cell line is also employed in assays studying glioblastoma’s invasive and migratory properties, as it effectively mimics the highly invasive nature of GBM in vitro. Moreover, proteomic analyses of SNB-19 have contributed to understanding protein-level dysregulations and their correlation with genetic alterations in glioblastoma. These characteristics make SNB-19 an essential tool in translational research focused on glioblastoma.